Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


A mouse model for testing remyelinating therapies.

Bai CB, Sun S, Roholt A, Benson E, Edberg D, Medicetty S, Dutta R, Kidd G, Macklin WB, Trapp B.

Exp Neurol. 2016 Sep;283(Pt A):330-40. doi: 10.1016/j.expneurol.2016.06.033.


Thalamocortical-auditory network alterations following cuprizone-induced demyelination.

Ghaffarian N, Mesgari M, Cerina M, Göbel K, Budde T, Speckmann EJ, Meuth SG, Gorji A.

J Neuroinflammation. 2016 Jun 22;13(1):160. doi: 10.1186/s12974-016-0629-0.


Salvianolic acid B protects the myelin sheath around injured spinal cord axons.

Zhu Z, Ding L, Qiu WF, Wu HF, Li R.

Neural Regen Res. 2016 Mar;11(3):487-92. doi: 10.4103/1673-5374.179068.


Inherited and acquired disorders of myelin: The underlying myelin pathology.

Duncan ID, Radcliff AB.

Exp Neurol. 2016 Sep;283(Pt B):452-75. doi: 10.1016/j.expneurol.2016.04.002. Review.


Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Wheeler NA, Fuss B.

Exp Neurol. 2016 Sep;283(Pt B):512-30. doi: 10.1016/j.expneurol.2016.03.019. Review.


Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.

Schott JT, Kirby LA, Calabresi PA, Baxi EG.

J Vis Exp. 2016 Feb 17;(108):53764. doi: 10.3791/53764.


Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.

Gautier HO, Evans KA, Volbracht K, James R, Sitnikov S, Lundgaard I, James F, Lao-Peregrin C, Reynolds R, Franklin RJ, Káradóttir RT.

Nat Commun. 2015 Oct 6;6:8518. doi: 10.1038/ncomms9518.


Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.

Wootla B, Denic A, Watzlawik JO, Warrington AE, Rodriguez M.

Mol Neurobiol. 2016 Oct;53(8):5217-28. doi: 10.1007/s12035-015-9436-3. Review.


18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.

Zhou J, Cai W, Jin M, Xu J, Wang Y, Xiao Y, Hao L, Wang B, Zhang Y, Han J, Huang R.

Sci Rep. 2015 Sep 2;5:13713. doi: 10.1038/srep13713.


Translational control of myelin basic protein expression by ERK2 MAP kinase regulates timely remyelination in the adult brain.

Michel K, Zhao T, Karl M, Lewis K, Fyffe-Maricich SL.

J Neurosci. 2015 May 20;35(20):7850-65. doi: 10.1523/JNEUROSCI.4380-14.2015.


Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.

Keough MB, Jensen SK, Yong VW.

J Vis Exp. 2015 Mar 26;(97). doi: 10.3791/52679.


Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Shi H, Hu X, Leak RK, Shi Y, An C, Suenaga J, Chen J, Gao Y.

Exp Neurol. 2015 Oct;272:17-25. doi: 10.1016/j.expneurol.2015.03.017. Review.


The axon-glia unit in white matter stroke: mechanisms of damage and recovery.

Rosenzweig S, Carmichael ST.

Brain Res. 2015 Oct 14;1623:123-34. doi: 10.1016/j.brainres.2015.02.019. Review.


The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.

Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M.

Br J Pharmacol. 2015 Jan;172(1):80-92. doi: 10.1111/bph.12938.


The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.

Stoffels JM, Hoekstra D, Franklin RJ, Baron W, Zhao C.

Glia. 2015 Feb;63(2):242-56. doi: 10.1002/glia.22748.


Overexpression of polysialylated neural cell adhesion molecule improves the migration capacity of induced pluripotent stem cell-derived oligodendrocyte precursors.

Czepiel M, Leicher L, Becker K, Boddeke E, Copray S.

Stem Cells Transl Med. 2014 Sep;3(9):1100-9. doi: 10.5966/sctm.2014-0041.


Zebrafish regenerate full thickness optic nerve myelin after demyelination, but this fails with increasing age.

Münzel EJ, Becker CG, Becker T, Williams A.

Acta Neuropathol Commun. 2014 Jul 15;2:77. doi: 10.1186/s40478-014-0077-y.


Promoting return of function in multiple sclerosis: An integrated approach.

Gacias M, Casaccia P.

Mult Scler Relat Disord. 2013 Oct 1;2(4). doi: 10.1016/j.msard.2013.04.002.


Promoting remyelination in multiple sclerosis-recent advances.

Münzel EJ, Williams A.

Drugs. 2013 Dec;73(18):2017-29. doi: 10.1007/s40265-013-0146-8. Review. Erratum in: Drugs. 2014 Jan;74(1):157. Jolanda Münzel, E [corrected to Münzel, E Jolanda].

Items per page

Supplemental Content

Support Center